

06 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/06/3183076/0/en/Cardiff-Oncology-Reports-Third-Quarter-2025-Results-and-Provides-Business-Update.html

30 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/investors-whale-cardiff-sinking-stock-after-seeing-updated-colorectal-cancer-data

15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3062116/0/en/Cardiff-Oncology-Announces-Completion-of-Enrollment-in-Phase-2-CRDF-004-Trial-Evaluating-Onvansertib-for-the-Treatment-of-First-line-RAS-mutated-Metastatic-Colorectal-Cancer.html

01 Mar 2024
// Ayisha Sharma ENDPTS
https://endpts.com/cardiff-teases-plk1-inhibitor-efficacy-in-colorectal-cancer-ahead-of-first-line-readout/

12 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cardiff-oncology-announces-plans-for-a-randomized-trial-in-metastatic-colorectal-cancer-mcrc-durability-of-responses-in-ongoing-phase-1b2-trial-in-mcrc-and-additional-business-updates-301622266.html

11 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cardiff-oncology-announces-new-preclinical-and-clinical-data-from-program-in-kras-mutated-metastatic-colorectal-cancer-mcrc-at-the-esmo-congress-2022-301621536.html